Sustained βAR stimulation mediates cardiac insulin resistance in a PKA-dependent manner

Molecular Endocrinology

Volumn 30, Issue 1, 2016, Pages 118-132

  Mangmool, Supachoke ^a,b   Denkaew, Tananat ^a   Phosri, Sarawuth ^a   Pinthong, Darawan ^c   Parichatikanond, Warisara ^a   Shimauchi, Tsukasa ^d,e   Nishida, Motohiro ^d,e,f  

^a Department of Pharmacology and Center of Excellence for Innovation in Drug Design and Discovery ^*  (United States)

^b MAHIDOL UNIVERSITY   (Thailand)

^c NATIONAL INSTITUTE FOR PHYSIOLOGICAL SCIENCES   (Japan)

^d KYUSHU UNIVERSITY   (Japan)

^e Precursory Research for Embryonic Science and Technology   (Japan)

^f JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ATENOLOL; CYCLIC AMP DEPENDENT PROTEIN KINASE; GLUCOSE; GLUCOSE TRANSPORTER 4; INSULIN; ISOPRENALINE; METOPROLOL; PROPRANOLOL; BETA ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BETA ADRENERGIC STIMULATION; CELL MEMBRANE; CONTROLLED STUDY; DRUG EFFECT; GLUCOSE TRANSPORT; HEART; HEART MUSCLE CELL; HUMAN; HUMAN CELL; INSULIN RESISTANCE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; ANIMAL; CARDIAC MUSCLE; CARDIAC MUSCLE CELL; DRUG EFFECTS; HEK293 CELL LINE; METABOLISM; PHYSIOLOGY; RAT; SIGNAL TRANSDUCTION;

ADRENERGIC BETA-AGONISTS; ADRENERGIC BETA-ANTAGONISTS; ANIMALS; CYCLIC AMP-DEPENDENT PROTEIN KINASES; GLUCOSE TRANSPORTER TYPE 4; HEK293 CELLS; HUMANS; INSULIN RESISTANCE; ISOPROTERENOL; METOPROLOL; MICE; MYOCARDIUM; MYOCYTES, CARDIAC; PROPRANOLOL; RATS; RECEPTORS, ADRENERGIC, BETA; SIGNAL TRANSDUCTION;

EID: 84953212764     PISSN: 08888809     EISSN: 19449917     Source Type: Journal    
DOI: 10.1210/me.2015-1201     Document Type: Article

References (42)

1. Mlinar B, Marc J, Janez A, Pfeifer M. Molecular mechanisms of insulin resistance and associated diseases. Clin Chim Acta. 2007; 375(1-2):20-35
2. Shah A, Shannon RP. Insulin resistance in dilated cardiomyopathy. Rev Cardiovasc Med. 2003;4 suppl 6:S50-S57
3. Mancia G, Grassi G, Giannattasio C, Seravalle G. Sympathetic activation in the pathogenesis of hypertension and progression of organ damage. Hypertension. 1999;34(4 pt 2):724-728
4. Lohse MJ, Engelhardt S, Eschenhagen T. What is the role of β-adrenergic signaling in heart failure? Circ Res. 2003;93(10):896-906
5. Morisco C, Condorelli G, Trimarco V, et al. Akt mediates the cross-talk between β-adrenergic and insulin receptors in neonatal cardiomyocytes. Circ Res. 2005;96(2):180-188
6. Heather LC, Catchpole AF, Stuckey DJ, Cole MA, Carr CA, Clarke K. Isoproterenol induces in vivo functional and metabolic abnormalities: similar to those found in the infarcted rat heart. J Physiol Pharmacol. 2009;60(3):31-39
7. Kashiwagi A, Huecksteadt TP, Foley JE. The regulation of glucose transport by cAMP stimulators via three different mechanisms in rat and human adipocytes. J Biol Chem. 1983;258(22):13685-13692
8. Kirsch DM, Baumgarten M, Deufel T, Rinninger F, Kemmler W, Häring HU. Catecholamine-induced insulin resistance of glucose transport in isolated rat adipocytes. Biochem J. 1983;216(3):737-745
9. Jost P, Fasshauer M, Kahn CR, et al. Atypical β-adrenergic effects on insulin signaling and action in β(3)-adrenoceptor-deficient brown adipocytes. Am J Physiol Endocrinol Metab. 2002;283(1): E146-E153
10. Chiasson JL, Shikama H, Chu DT, Exton JH. Inhibitory effect of epinephrine on insulin-stimulated glucose uptake by rat skeletal muscle. J Clin Invest. 1981;68(3):706-713
11. Murray AJ, Lygate CA, Cole MA, et al. Insulin resistance, abnormal energy metabolism and increased ischemic damage in the chronically infarcted rat heart. Cardiovasc Res. 2006;71(1):149-157
12. Cohn JN, Levine TB, Olivari MT, et al. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med. 1984;311(13):819-823
13. Ciccarelli M, Chuprun JK, Rengo G, et al. G protein-coupled receptor kinase 2 activity impairs cardiac glucose uptake and promotes insulin resistance after myocardial ischemia. Circulation. 2011;123(18):1953-1962
14. Bos JL. Epac proteins: multi-purpose cAMP targets. Trends Biochem Sci. 2006;31(12):680-686
15. Mangmool S, Shukla AK, Rockman HA. β-Arrestin-dependent activation of Ca(2)/calmodulin kinase II after β(1)-adrenergic receptor stimulation. J Cell Biol. 2010;189(3):573-587
16. Mulder AH, Tack CJ, Olthaar AJ, Smits P, Sweep FC, Bosch RR. Adrenergic receptor stimulation attenuates insulin-stimulated glucose uptake in 3T3-L1 adipocytes by inhibiting GLUT4 translocation. Am J Physiol Endocrinol Metab. 2005;289(4):E627-E633
17. Cipolletta E, Campanile A, Santulli G, et al. The G protein coupled receptor kinase 2 plays an essential role in β-adrenergic receptorinduced insulin resistance. Cardiovasc Res. 2009;84(3):407-415
18. Bangalore S, Messerli FH, Kostis JB, Pepine CJ. Cardiovascular protection using β-blockers: a critical review of the evidence. J Am Coll Cardiol. 2007;50(7):563-572
19. Mangmool S, Hemplueksa P, Parichatikanond W, Chattipakorn N. Epac is required for GLP-1R-mediated inhibition of oxidative stress and apoptosis in cardiomyocytes. Mol Endocrinol. 2015;29(4): 583-596
20. Mangmool S, Haga T, Kobayashi H, et al. Clathrin required for phosphorylation and internalization of β2-adrenergic receptor by G protein-coupled receptor kinase 2 (GRK2). J Biol Chem. 2006; 281(42):31940-31949
21. Métrich M, Lucas A, Gastineau M, et al. Epac mediates β-adrenergic receptor-induced cardiomyocyte hypertrophy. Circ Res. 2008; 102(8):959-965
22. Pereira L, Metrich M, Fernandez-Velasco M, et al. The cAMP binding protein Epac modulates Ca2 sparks by a Ca2 /calmodulin kinase signalling pathway in rat cardiac myocytes. J Physiol. 2007; 583(pt 2):685-694
23. Thomas RF, Holt BD, Schwinn DA, Liggett SB. Long-term agonist exposure induces upregulation of β 3-adrenergic receptor expression via multiple cAMP response elements. Proc Natl Acad Sci USA. 1992;89(10):4490-4494
24. Jellinger PS. Metabolic consequences of hyperglycemia and insulin resistance. Clin Cornerstone. 2007;8(suppl 7):S30-S42
25. Swan JW, Anker SD, Walton C, et al. Insulin resistance in chronic heart failure: relation to severity and etiology of heart failure. J Am Coll Cardiol. 1997;30(2):527-532
26. Witteles RM, Fowler MB. Insulin-resistant cardiomyopathy clinical evidence, mechanisms, and treatment options. J Am Coll Cardiol. 2008;51(2):93-102
27. Belke DD, Larsen TS, Gibbs EM, Severson DL. Altered metabolism causes cardiac dysfunction in perfused hearts from diabetic (db/db) mice. Am J Physiol Endocrinol Metab. 2000;279(5): E1104-E1113
28. Mazumder PK, O’Neill BT, Roberts MW, et al. Impaired cardiac efficiency and increased fatty acid oxidation in insulin-resistant ob/ob mouse hearts. Diabetes. 2004;53(9):2366-2374
29. Boudina S, Bugger H, Sena S, et al. Contribution of impaired myocardial insulin signaling to mitochondrial dysfunction and oxidative stress in the heart. Circulation. 2009;119(9):1272-1283
30. van Putten JP, Krans HM. Long-term regulation of hexose uptake by isoproterenol in cultured 3T3 adipocytes. Am J Physiol. 1985; 248(6 pt 1):E706-E711
31. Joost HG, Steinfelder HJ. Forskolin inhibits insulin-stimulated glucose transport in rat adipose cells by a direct interaction with the glucose transporter. Mol Pharmacol. 1987;31(3):279-283
32. Kaestner KH, Flores-Riveros JR, McLenithan JC, Janicot M, Lane MD. Transcriptional repression of the mouse insulin-responsive glucose transporter (GLUT4) gene by cAMP. Proc Natl Acad Sci USA. 1991;88(5):1933-1937
33. Klein J, Fasshauer M, Ito M, Lowell BB, Benito M, Kahn CR. β(3)-adrenergic stimulation differentially inhibits insulin signaling and decreases insulin-induced glucose uptake in brown adipocytes. J Biol Chem. 1999;274(49):34795-34802
34. Cong M, Perry SJ, Lin FT, et al. Regulation of membrane targeting of the G protein-coupled receptor kinase 2 by protein kinase A and its anchoring protein AKAP79. J Biol Chem. 2001;276(18):15192-15199
35. Murthy KS, Mahavadi S, Huang J, Zhou H, Sriwai W. Phosphorylation of GRK2 by PKA augments GRK2-mediated phosphorylation, internalization, and desensitization of VPAC2 receptors in smooth muscle. Am J Physiol Cell Physiol. 2008;294(2):C477-C487
36. Iaccarino G, Barbato E, Cipolleta E, et al. Cardiac βARK1 upregulation induced by chronic salt deprivation in rats. Hypertension. 2001;38(2):255-260
37. Sucharov CC, Mariner PD, Nunley KR, Long C, Leinwand L, Bristow MR. A β1-adrenergic receptor CaM kinase II-dependent pathway mediates cardiac myocyte fetal gene induction. Am J Physiol Heart Circ Physiol. 2006;291(3):H1299-H1308
38. Communal C, Singh K, Sawyer DB, Colucci WS. Opposing effects of β(1)and β(2)-adrenergic receptors on cardiac myocyte apoptosis: role of a pertussis toxin-sensitive G protein. Circulation. 1999; 100(22):2210-2212
39. Shiina T, Kawasaki A, Nagao T, Kurose H. Interaction with β-arrestin determines the difference in internalization behavor between β1and β2-adrenergic receptors. J Biol Chem. 2000;275(37): 29082-29090
40. Yoo B, Lemaire A, Mangmool S, et al. β1-adrenergic receptors stimulate cardiac contractility and CaMKII activation in vivo and enhance cardiac dysfunction following myocardial infarction. Am J Physiol Heart Circ Physiol. 2009;297(4):H1377-H1386
41. Hoffmann C, Leitz MR, Oberdorf-Maass S, Lohse MJ, Klotz KN. Comparative pharmacology of human β-adrenergic receptor subtypescharacterization of stably transfected receptors in CHO cells. Naunyn Schmiedebergs Arch Pharmacol. 2004;369(2):151-159
42. Doggrell SA, Henderson CJ. The offset of β-adrenoceptor antagonism of the responses of the rat right ventricle to isoprenaline. J Auton Pharmacol. 1998;18(5):263-269